In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis

EuroIntervention

Volumn 7, Issue 12, 2012, Pages 1461-1463

  Radu, Maria D ^a   Onuma, Yoshinobu ^a   Rapoza, Richard J ^b   Diletti, Roberto ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ABBOTT VASCULAR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLACTIC ACID; TISSUE SCAFFOLD;

ARTICLE; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DEVICE SAFETY; ENERGY ABSORPTION; EQUIPMENT DESIGN; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; MATERIAL COATING; MECHANICAL STRESS; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SEPARATION TECHNIQUE; SIGNAL DETECTION; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY STENOSIS; HUMANS; IMAGING, THREE-DIMENSIONAL; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84860737544     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I12A227     Document Type: Article

References (5)

1. American Society of Metals. Characterization and Failure Analysis of Plastics. ASM International 2003;204-210.
2. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
3. Radu M, Jørgensen E, Kelbaek H, Helqvist S, Skovgaard L, Saunamäki K. Strut apposition after coronary stent implantation visualised with optical coherence tomography. EuroIntervention 2010;6:86-93.
4. Onuma Y, Serruys PW, Ormiston JA, Regar E, Webster M, Thuesen L, Dudek D, Veldhof S, Rapoza R. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 2010;6:447-453.
5. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 2010;122:2301-2312.